Atrial Natriuretic Peptide in Renal Transplantation

Hormone Research in Paediatrics

Volumn 46, Issue 2, 1996, Pages 74-82

  Plum, J ^a   Scholtz, W ^a   Grabensee, B ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atrial natriuretic peptide; Kidney transplantation; Transplant function

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE DERIVATIVE; CREATININE; VASOPRESSIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; FEMALE; FLUID BALANCE; FREE WATER CLEARANCE; HORMONE BLOOD LEVEL; HUMAN; HYDRATION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; VASOPRESSIN BLOOD LEVEL;

EID: 0029775103     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185000     Document Type: Article

References (47)

1. De Bold AJ, Borenslein HB, Verecs AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats, Life Sei 1981:28:89-94.
2. Ballermann BJ, Brenner BM: Biologically active atrial peptides, J Clin Invest 1985;76: 1145-1147.
3. Kangawa K, Fukuda A, Matsuo H: Purification and complete amino acid sequence of alpha-human atrial polypeptides (alpha-ANP), Bio-chem Biophys Res Commun 1984;118:1 Slug.
4. Anderson JV, Gibbs R, Woodruff PWR, et al: Atrial natriuretic peptide: Physiological release associated with natriuresis during water immersion in man, Clin Sci 1986;71:319-322.
5. Cuneo RC, Espincr EA, Nicholls MG, et al: Renal hemodynamic and hormonal responses to atrial natriuretic peptide infusions in normal man and effect of sodium intake, J Clin Endocrinol Metab 1986:63:946-953.
6. Espiner EA, Nicholls MG, Yandle TG, et at: Studies on the secretion, metabolism and action of atrial natriuretic peptide in man, J Hypertens 1986;4(suppl 2):85-91.
7. Hodsman GP, Tsunoda K, Ogawa K, et al: Effect of posture on circulating atrial natriuretic peptide, Lancet 1985;2: 1427.
8. Gerbes AL, Arendt RM, Gerzer R, et al: Role of atrial natriuretic factor, cyclic GMP and the rcnin-aldostcrone system in acute volume regulation of healthy subjects, Eur J Clin Invest 1988:18:425-429.
9. Rascher W, Tulassay T, Lang T, Lang RE: Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure, Lancet 1985;2:303-305.
10. Ricggcr AJG, Kramer EP, Kochsiek K: Der natriuretische Vorhoffaktor bei schwerer kongestiver Herzinsuffizienz, Dtsch Med Wo-chenschr 1985;110:1607-1610.
11. Brickcr NS: The control of sodium excretion with normal and reduced nephron populations, Am J Med 1967;43:313-321.
12. Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J: Change in plasma immuno-reactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis, Clin Sei 1986;71:157-160.
13. Anderson JV, Raine AEG, Proudlcr A, Bloom SR: Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure, J Endocrinol 1986;110:193-196.
14. Eisenhaucr T, Talartschik J, Quentin E, Kreutzfcldt W, Scheler F: Beeinflussung von atrialem natriuretischen Peptid (ANP) und zyklischem GMP durch Haemofiltration und Hacmodialyse, Klin Wochcnschr I988;66: 940-945.
15. Plum J, Grabcnsce B: Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis, J Intern Med 1991;229: 243-254.
16. Kokot F, Wiccek A: Endocrine changes in chronic dialysis patients; in Malier JF (ed): Replacement of Renal Function by Dialysis, ed 3, London, Kluwer Academic Publishers, 1989, pp 916-934.
17. Zuber M, Kiowski W, Huser B, Erne P, Biihler FR, Thiel G: Atrial natriuretic peptide release and volume regulation following kidney transplantation, Clin Nephrol 1993;40:91-95.
18. Crum R, Fairchild R, Bronsther O, Dominic W, Ward D, Fernandez R, Brown MR: Neuroendocrinology of chronic renal failure and renal transplantation, Transplantation 1991: 52:818-823.
19. Woolf AS, Simpson KL, Mansell MA, Moult PJA: The effect or renal transplantation on plasma atrial natriuretic peptide, Nephrol Dial Transplant 1988:2:205-208.
20. Doorenbos CJ, Daha MR, van Brummelcn P: Correlates of plasma atrial natriuretic peptide levels in renal transplant recipients, Clin Nephrol 1989;31:146-149.
21. Raine AEG, Anderson JV, Bloom SR, Morris PJ: Plasma atrial natriuretic factor and graft function in renal transplant recipients, Transplant 1990;5:796-800.
22. Plum J, Sprenger KBG, Heering P, Grabensee B: Vergleichende methodische Untersuchung zur radioimmunologischcn Bestimmung des Atrialen Natriuretischen Peptids (ANP), Nieren- Hochdruckkrankh 1986;9:388.
23. Sole MJ, Hussain MN: A simple specific ra-dioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine and dopamine in plasma and tissues, Biochem Med 1977; 18:301-307.
24. Bortz J: Statistik fiirSozialwissenschaftler, Berlin, Springer, 1989, pp 263-264.
25. Rosenthal R: Judgement studies, Design, Analysis and Meta-Analysis, Cambridge, Cambridge University Press, 1987, pp 188-192.
26. Toledo-Perevra L: Kidney Transplantation, Philadelphia, Davies, 1988.
27. Campese VM, Iseki K, Massry SG: Plasma catecholamines and vascular reactivity in uremic and dialysis patients, C'ontrib Nephrol, Basel, Karger, vol 41, pp 90-98.
28. Plum J, Ziyaie M, Kemmcr FW, Passlick-Deetjen J, Grabensee B: Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD, Adv Pcriton Dial 1990;6:211-219.
29. Richards AM, Tonolo G, Monlorsi P, et al: Low dose infusions of 26- and 28-antino acid human atrial natriuretic peptides in normal man, J Clin Endocrinol Metab 1988:66:465-472.
30. Meyer-Lehnert H, Bayer T, Predel HG, Glän-zer K, Kramer HJ: Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure, Klin Wochenschr 1991; 69:895-903.
31. Tonolo C, McMillan M, Polonia J, et al: Plasma clearance and effect of alpha-human ANP infusion in patients with end stage renal disease, Am J Physiol 1988:254:F895-899.
32. Sugahara S, Koyama I, Yoshikawa Y, Dohi Y, Omoto R: Plasma atrial natriuretic peptide, renin activity, and aldosterone in changes of body fluid volume after renal transplantation, Transplant Proc 1992;4:1576-1577.
33. Nyberg G, Herlitz H, Bjorck S, Karlberg I, Hcdner T, Hedner JAD: Acute and long-term changes in plasma levels of atrial natriuretic factor in patients with renal replacement therapy, Transplant Int 1990;3:195-198.
34. Maack T: Receptors of at rial natriuretic factor, Ann Rev Physiol 1992;54:11-27.
35. Olins GM, Spear KL, Siegel NR, Zürcher Neely HA: Inactivation of atrial natriuretic factor by the renal brush border, Biochim Biophys Acta 1987;901:97-100.
36. Pham I, El-Antrani AIK, Foumie Zaluski MC, Corvol P, Roques B, Michel JB: Effects of the selective neutral endopcptidasc inhibitor, rct-rothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats, J Cardiovasc Pharmacol 1992;20:847-857.
37. Connell JMC, Whitworth JA, Davies DL, Richards AM, Fraser R: Haemodynamic, hormonal and renal effects of adrenocorticotro-phic hormone in sodium-restricted man, J Hy-pertens 1988;6:17-23.
38. Argentin S, Sun YL, Lihrmann I, Schmidt TJ, Drouin J, Nemer D: Distal cis-acting promoter sequences mediate glucocorticoid stimulation of cardiac atrial natriuretic factor gene transcription, J Biol Chem 1991:266:23315-23322.
39. Weidmann P, Matter DR, Matter EE, et al: Glucocorticoid and mincralcorticoid stimulation of atrial natriuretic peptide release in man, J Clin Endocrinol Melab 1988:66:1233-1239.
40. Weidmann P, Haslcr L, Gniidinger MPP, Lang RE, Uehlingcr DE, Shaw S, Rascher W, Reubi FC: Blood levels and renal effects of atrial natriuretic peptide in normal man, J Clin Invest 1986;77:734-742.
41. De Zeeuw D, Janssen WMT, Dc Jong PE: Atrial natriuretic factor: Its (patho)physiologi-cal significance in human, Kidney Int 1992:41: 1115-1133.
42. Zeidel ML, Silva P, Brenner BM, Seifter JL: cGMP mediates effects of atrial peptides on medullary collecting duct cells, Am J Physiol 1987:252:F551.
43. Pruszczynski W, Drieu L, Cabrol C, Rondeau E, Ardaillou R: Renal response to volume expansion in heart-transplant and kidney-trans-plant recipients, Clin Nephrol 1987;28:65-72.
44. Pedersen EB, Danielsen H, Nielsen AH, Knudsen F, Jensen T, Kornerup HJ, Madsen M: Effect of exercise on plasma concentrations of arginine vasopressin, angiotensin II and aldosterone in hypertensive and normotensive renal transplant recipients, Scand J Clin Lab Invest 1986;46:151-157.
45. McGrath BP, Ledingham JGG, Benedict CR: Catecholamines in peripheral venous plasma in patients on chronic hemodialysis, Clin Sei Mol Med 1978;55:89-96.
46. Winaver J, Burnett JC, Tycc GM, Dousa TP: ANP inhibits Na(+)-H(+) antiport in proximal tubular brush border membrane: Role of dopamine, Kidney Int 1990:38:1133-1140.
47. Castejano M, Beschi M, Agabiti Rosei E, Riz-zoni D, Rossini P, Poiesi C, Pizzocolo G, Alberini A, Muiesan G: Renal and hemodynamic effects of atrial natriuretic peptide infusion are not mediated by peripheral dopaminergic mechanisms, Am J Hypcrtens 1991:4: 385-388.